QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 260 filers reported holding QIAGEN NV in Q1 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,386,720 | +140.9% | 34,240 | +167.8% | 0.01% | +150.0% |
| Q2 2023 | $575,709 | +1029.2% | 12,785 | +1051.8% | 0.00% | – |
| Q1 2023 | $50,982 | -98.1% | 1,110 | -97.9% | 0.00% | -100.0% |
| Q4 2022 | $2,658,869 | +64.2% | 53,316 | +35.9% | 0.01% | +100.0% |
| Q3 2022 | $1,619,000 | -20.9% | 39,229 | -9.5% | 0.00% | 0.0% |
| Q2 2022 | $2,047,000 | +214.9% | 43,365 | +226.9% | 0.00% | +200.0% |
| Q1 2022 | $650,000 | -57.5% | 13,265 | -51.8% | 0.00% | 0.0% |
| Q4 2021 | $1,529,000 | +382.3% | 27,510 | +348.5% | 0.00% | – |
| Q3 2021 | $317,000 | -58.1% | 6,134 | -60.8% | 0.00% | -100.0% |
| Q2 2021 | $756,000 | -46.0% | 15,632 | -45.7% | 0.00% | -50.0% |
| Q1 2021 | $1,401,000 | -34.3% | 28,782 | -29.5% | 0.00% | -71.4% |
| Q3 2020 | $2,132,000 | +864.7% | 40,800 | +689.6% | 0.01% | +600.0% |
| Q2 2020 | $221,000 | -89.5% | 5,167 | -89.8% | 0.00% | -94.1% |
| Q1 2020 | $2,105,000 | +1076.0% | 50,591 | +775.6% | 0.02% | +1600.0% |
| Q4 2017 | $179,000 | – | 5,778 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 4,177,260 | $158,235,000 | 6.82% |
| Exane Asset Management | 522,037 | $19,742,931,000 | 6.18% |
| Tikvah Management LLC | 442,942 | $16,779,000 | 5.01% |
| Opus Point Partners Management, LLC | 31,620 | $1,198,000 | 2.86% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,600,672 | $98,144,000 | 2.79% |
| RTW INVESTMENTS, LP | 775,324 | $29,369,000 | 1.76% |
| SANDLER CAPITAL MANAGEMENT | 787,529 | $29,832,000 | 1.51% |
| FRIESS ASSOCIATES LLC | 531,900 | $20,148,000 | 1.40% |
| Sivik Global Healthcare LLC | 85,000 | $3,220,000 | 1.15% |
| Parametrica Management Ltd | 11,940 | $452,000 | 0.99% |